MoneyWorks4Me

Alkem Laboratories informs about press release

22 Sep 2025 Evaluate
Alkem Laboratories has informed that the company launches Pertuza, a pertuzumab biosimilar, in India for treatment of HER2-positive breast cancer. A press release in this regard is enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1792.25
Dr. Reddys Labs. 1199.40
Cipla 1332.50
Lupin 2010.95
Zydus Lifesciences 1131.60
View more..